Mechanistically, CLTB enhances the cellular uptake of sEVs by coordinating the NF‐κB–proliferating cell nuclear antigen (PCNA) clamp‐associated factor (PCLAF/KIAA0101) axis, thereby promoting HCC progression. The gene discussed is PCLAF; the disease is hepatocellular carcinoma.